FENC Fennec Pharmaceuticals Inc.
$11.62
Fennec Pharmaceuticals Inc. (FENC) Earnings News
Earnings press releases, previews and reviews for Fennec Pharmaceuticals Inc. (FENC), newest first. Our most recent is review: Fennec Pharmaceuticals Converts PEDMARK Momentum Into a 30% EBITDA Margin, Even as Year-Over-Year Growth Cools and Guidance Stays Absent.
Thursday
November 12, 2026
10:49 AM ET
Fennec Pharmaceuticals Converts PEDMARK Momentum Into a 30% EBITDA Margin, Even as Year-Over-Year Growth Cools and Guidance Stays Absent
Earnings Whispers · Review
Thursday
November 12, 2026
6:03 AM ET
Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Friday
November 6, 2026
2:31 PM ET
Fennec's Record July Meets a Sliding Stock as Project Ignite Faces Its Proof Quarter
Earnings Whispers · Preview
Friday
November 6, 2026
5:50 AM ET
Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
Tuesday
August 11, 2026
7:01 AM ET
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Wednesday
August 5, 2026
7:01 AM ET
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026